Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sciomics logo — Protein and post-translational modification profiling for pr...

Sciomics

Protein and post-translational modification profiling for precision medicine

Founded 2013 Germany Germany 13 employees Biotechnology, Health Care

General Information

Company Name Sciomics
Founded Year 2013
Location Germany Germany +1
Founders / Decision Makers
Team member
Employees 13
Industries Biotechnology, Health Care
Social

Get notified when Sciomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sciomics

Protein profiling plays a crucial role in the advancement of biomedical research, enabling us to improve patients' quality of life by utilizing molecular signatures for accurate diagnosis and treatment. At Sciomics, our passion for advanced protein profiling is driving the future of Precision Medicine. We are continually expanding our biomarker signature pipeline to address a wide range of clinical indications and to advance Precision Diagnostics. Our cutting-edge services enable scientists worldwide to unravel the complexities of disease, uncover modes of action and identify promising protein biomarker candidates. Our service portfolio is anchored in our state-of-the-art scioDiscover microarray platform for protein and post-translational modification profiling. We are proud to support a wide range of research, from basic scientific discovery to breakthrough pharmaceutical initiatives (R&D). scioDiscover is a high-content, high-throughput system that provides a fast and cost-effective solution to your research needs. Its results are seamlessly translated into validation and clinical assays, enabling breakthrough biomarker discovery and preclinical drug development. Our team is dedicated to supporting you throughout your project: Project Planning: From planning to execution, we will help you navigate the most efficient route to achieve your research objectives. Technical Expertise: Our team provides unmatched proficiency in your proteomic analysis endeavors. Customized Solutions: We provide customized solutions to meet your specific research needs. Comprehensive Study Report: Our services include a comprehensive data analysis and a customized report. Our Platform Is Used For: • Protein Biomarker Identification and Verification • Novel Drug Target Discovery • Mode-of-Action Analysis • Pathway Activity Analysis • Disease Model Characterization, among other key applications Join us on our mission to revolutionize medicine! #PrecisionMedicine #Proteomics

No funding data available for Sciomics yet.

Get notified when Sciomics raises funding

Sciomics Alternatives & Competitors

Sciomics vs
ACT Genomics
ACT Genomics Taiwan

Make Personalized Medicine Accessible To All.

Series Unknown
121 employees
Biotechnology, Health Care
Sciomics vs
Adeptrix Corporation
Adeptrix Corporation United States

Bioanalytical Services (Discovery & Translational Research)

5 employees
Sciomics vs
BioLum Sciences
BioLum Sciences United States

Transforming Precision Drug Discovery and Early Detection of Disease

Grant
5 employees
Biotechnology, Digital Health

FAQ About Sciomics

Protein and post-translational modification profiling for precision medicine
Sciomics was founded in 2013.
Sciomics is headquartered in Germany.
Sciomics operates in the following industries: Biotechnology, Health Care.
Sciomics has approximately 13 employees.
Top alternatives and competitors to Sciomics include ACT Genomics, Adeptrix Corporation, BioLum Sciences, Ayass BioScience, LLC, Truly Labs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sciomics and ACT Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sciomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy